Latest Reports
Brazil Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The Brazilian anti-rheumatic drugs market was valued at US$2,400.050 million in 2020. The market is projected to grow at a CAGR of 2.41% to attain a value of US$2,836.140 million by 2027. The growing ageing population in Brazil is the major...
Germany Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Germany’s antirheumatic drug market was valued at US$7,533.165 million in 2020. The market is projected to grow at a CAGR of 4.08% to attain a value of US$9,964.630 million by 2027. The antirheumatic drug market in Germany is projecte...
France Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
France’s antirheumatic drugs market was valued at US$5,459.428 million in 2020. The market is projected to grow at a CAGR of 3.34% to attain a value of US$6,870.348 million by the year 2027. The antirheumatic drugs market in France is...
Middle East And Africa (MEA) Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The Middle East and Africa (MEA) anti-rheumatic drug market was valued at US$3,774.467 million in 2020. The market is projected to grow at a CAGR of 1.96% to attain a value of US$4,562.505 million by 2027. The market in the Middle East and ...
South America Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The South American antirheumatic drugs market was valued at US$6,851.495 million in 2020. The market is projected to grow at a CAGR of 2.36% to attain a value of US$8,067.500 million by 2027. Countries like Brazil, Argentina, Peru, and Colo...
United States Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The United States antirheumatic drugs market was valued at US$115.485 billion in 2020. The market is projected to grow at a CAGR of 3.40% to attain a value of US$145.905 billion by 2027. As per the data from the World Bank Group, the popula...
United Kingdom Anti-Rheumatic Drug Market - Strategic Insights and Forecasts (2022-2027)
The United Kingdom’s antirheumatic drug market was valued at US$4,325.221 million in 2020. The market is projected to grow at a CAGR of 3.93% to attain a value of US$5,664.104 million by 2027. The market in the United Kingdom is proje...
Global Transdermal Patches Market Size, Share, Opportunities, And Trends By Transdermal Patch Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapour Patch, Matrix), By Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular, Others), And By Geography - Forecasts From 2025 To 2030
Global Transdermal Patches Market is projected to grow at a CAGR of 2.51% between 2025 to 2030. The market is projected to show steady growth primarily attributed to the success of transdermal patches in dealing with the issues concerns. T...
African Swine Fever Pipeline Analysis 2021- Focusing on clinical trials and Results, Drug Profiling, Patents, Collaboration, and other recent developments
African Swine Fever Pipeline Analysis 2021- focusing on clinical trials and results, drug profiling, patents, collaboration, and other recent developments. African Swine Fever (ASF) is a highly contagious disease affecting pigs and boars. ...
India E-Pharmacy Market Size, Share, Opportunities And Trends By Product Type (Skin Care, Dental, Cold and Flu, Vitamins, Others), By End Use (Hospitals, Personal use) - Forecasts From 2022 To 2027
The India E-Pharmacy market is projected to grow at a CAGR of 44.39% to reach US$5,467.390 million in 2024 from US$603.291 million in 2018. Today, e-commerce has become a thriving industry in India. Among the several segments of e-commerce,...
Idiopathic Pulmonary Fibrosis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments
Idiopathic Pulmonary Fibrosis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Idiopathic Pulmonary Fibrosis Pipeline Analysis report covers 57 drugs currently...
Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1)
Fibrodysplasia ossificans progressiva (FOP) Pipeline Analysis report covers more than 5 companies currently in different phases of development. Fibrodysplasia ossificans progressiva (FOP) is a congenital connective tissue disorder where ...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.